Earnings Call · Q3 FY2022·2022-11-12

Q3 22EPS +19.05%·Rev n/aQ2 22EPS +66.67%·Rev n/aQ1 22EPS -18.75%·Rev n/aQ4 21EPS +4.76%·Rev n/a⚠ consensus missing

BioCardia, Inc. BCDA

Jules Abraham — Investor Relations

Peter Altman — President and Chief Executive Officer

David McClung — Chief Financial Officer

+3.7%1d on move date+5.8% vs SPY3d0.0%5d+1.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCDA calls or request research access.

More BCDA calls Browse calls Request research access